Stelara 90 MG/ML syringeml
Ended Awarded
- Contract number
- SPE2DR26FBSDG
- Awardee
-
DMS Pharmaceutical Group Inc. UEI PX72BSBQTKJ3
- Awarding agency
-
Defense Logistics Agency
Department of Defense
- Obligated
- $33,168
Award facts
- Contract value 100% obligated
- $33,168.26 Current and potential, with all options
- Completion date 100% complete
- Current and potential, with all options
- NAICS code
- 424210 Drugs and Druggists' Sundries Merchant Wholesalers
- PSC
- 6505 Drugs And Biologicals
- Set-aside
- No set-aside
- Competition
- Full and Open Competition Negotiated Proposal / Quote
- Pricing
- Firm Fixed Price
- Place of performance
- Park Ridge, IL 60068, USA
Award details come from SAM.gov/FPDS.
About this award
The Defense Logistics Agency issued a delivery order valued at $33,168.26 to DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler based in Park Ridge, Illinois, for the supply of Stelara 90 mg/mL syringes. The contract, awarded on November 6, 2025, carries a firm fixed-price structure with an ultimate completion date of December 1, 2025, and includes no set-aside designation, demonstrating the vendor's competitive capability in unrestricted federal procurement. Performance will be fulfilled at the awardee's Park Ridge location.
This delivery order is issued under DMS Pharmaceutical Group's recently awarded single-award Indefinite Delivery Contract (IDC) with the Defense Logistics Agency's Pharmaceutical Prime Vendor Global Program Generation V (PPV-G GEN V) initiative, a $30.3 billion acquisition strategy designed to streamline pharmaceutical supply to Department of Defense military healthcare facilities worldwide. The parent IDC, valued at $499,999,999 with a completion date of December 31, 2036, authorizes DLA to issue firm fixed-price delivery orders for a comprehensive range of branded and generic pharmaceuticals, biologics, and medical consumables. DMS Pharmaceutical Group's established track record supplying specialized pharmaceutical products including immunosuppressants, biologics, oncology treatments, and vaccines positions the company as a critical supplier within the federal military medical supply chain.
Quick answers
Who was awarded contract SPE2DR26FBSDG?
SPE2DR26FBSDG was awarded to DMS Pharmaceutical Group Inc. by Defense Logistics Agency (Department of Defense) on November 6, 2025.
How much is contract SPE2DR26FBSDG worth?
The government has obligated $33,168 on SPE2DR26FBSDG.
Is contract SPE2DR26FBSDG an order under another contract?
Yes. SPE2DR26FBSDG is a delivery order under SPE2DR25D9158, an indefinite delivery contract.
Was contract SPE2DR26FBSDG competed?
The extent of competition for SPE2DR26FBSDG was full and open competition.
On GovTribe
See this award's full record
- Every transaction and funding action
- The awardee's other awards and teaming partners
- Similar awards and recompete opportunities
- Ask GovTribe AI about this award